PLN 9.19
(-3.26%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -31.71 Million PLN | -28.78% |
2022 | -24.62 Million PLN | -134.96% |
2021 | -10.48 Million PLN | 9.29% |
2020 | -11.55 Million PLN | -164.62% |
2019 | -4.36 Million PLN | -592.05% |
2018 | -631.01 Thousand PLN | -63.37% |
2017 | -386.24 Thousand PLN | 7.92% |
2016 | -419.45 Thousand PLN | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 486 Thousand PLN | 110.56% |
2024 Q1 | -4.6 Million PLN | 53.3% |
2023 Q3 | -6.25 Million PLN | 32.81% |
2023 Q4 | -9.85 Million PLN | -57.73% |
2023 Q1 | -6.3 Million PLN | 13.61% |
2023 Q2 | -9.3 Million PLN | -47.46% |
2023 FY | -31.71 Million PLN | -28.78% |
2022 Q2 | -5.53 Million PLN | -1.47% |
2022 Q4 | -7.3 Million PLN | -15.05% |
2022 FY | -24.62 Million PLN | -134.96% |
2022 Q1 | -5.45 Million PLN | -2798.02% |
2022 Q3 | -6.34 Million PLN | -14.77% |
2021 Q1 | -3.06 Million PLN | 31.04% |
2021 FY | -10.48 Million PLN | 9.29% |
2021 Q3 | -4.1 Million PLN | -16.84% |
2021 Q4 | 202 Thousand PLN | 104.92% |
2021 Q2 | -3.51 Million PLN | -14.79% |
2020 Q4 | -4.44 Million PLN | -75.56% |
2020 FY | -11.55 Million PLN | -164.62% |
2020 Q2 | -2.5 Million PLN | -59.69% |
2020 Q3 | -2.52 Million PLN | -0.92% |
2020 Q1 | -1.56 Million PLN | 19.37% |
2019 Q2 | -1.18 Million PLN | -261.63% |
2019 Q1 | -329 Thousand PLN | -43.02% |
2019 FY | -4.36 Million PLN | -592.05% |
2019 Q4 | -1.94 Million PLN | -115.85% |
2019 Q3 | -901.75 Thousand PLN | 24.21% |
2018 Q3 | -233.81 Thousand PLN | -124.41% |
2018 FY | -631.01 Thousand PLN | -63.37% |
2018 Q1 | -62.97 Thousand PLN | 11.83% |
2018 Q2 | -104.19 Thousand PLN | -65.45% |
2018 Q4 | -230.04 Thousand PLN | 1.61% |
2017 Q3 | 211.78 Thousand PLN | 0.0% |
2017 FY | -386.24 Thousand PLN | 7.92% |
2017 Q4 | -71.41 Thousand PLN | -133.72% |
2016 FY | -419.45 Thousand PLN | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Bioceltix S.A. | -15.81 Million PLN | -100.499% |
BIOTON S.A. | 15.29 Million PLN | 307.375% |
Captor Therapeutics Spolka Akcyjna | -73.01 Million PLN | 56.56% |
Mabion S.A. | 55.06 Million PLN | 157.605% |
Molecure S.A. | -22.1 Million PLN | -43.496% |
NanoGroup S.A. | -7.9 Million PLN | -301.397% |
Pharmena S.A. | 34.87 Million PLN | 190.958% |
Poltreg S.A. | -16.86 Million PLN | -88.103% |
Ryvu Therapeutics S.A. | -100.94 Million PLN | 68.58% |
Synthaverse S.A. | 8.64 Million PLN | 466.809% |
Urteste S.A. | -6.44 Million PLN | -391.981% |